Oct
29
Filed Under Articles, Bisphenol-A
From the Washington Post today:
In a highly critical report to be released today, the panel of scientists from government and academia said the FDA did not take into consideration scores of studies that have linked bisphenol A (BPA) to prostate cancer, diabetes and other health problems in animals when it completed a draft risk assessment of the chemical last month. The panel said the FDA didn’t use enough infant formula samples and didn’t adequately account for variations among the samples.
Taking those studies into consideration, the panel concluded, the FDA’s margin of safety is “inadequate”. The panel is part of the Science Board, a committee of advisers to the FDA commissioner, and was set up to review the FDA’s risk assessment of BPA.
I can’t even begin to express my utter frustration with the current state of Bisphenol-a in food packaging and baby products and this just solidifies the fact that this chemical has no business being near our food and that the FDA didn’t take real scientific evidence into consideration when they carelessly said it was safe.
Canada just recently declared BPA a dangerous toxin and has banned its use in childrens products.
Read the article on WashingtonPost.com
Related articles:
- FDA to continue to study BPA
- FDA Investigating Donation to Scientist Heading BPA Advisory Panel
- Bisphenol-A: How Much Evidence Do We Need?
